Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | PeptiCRAd-1 |
| Synonyms | |
| Therapy Description |
PeptiCRAd-1 is an oncolytic adenovirus encoding CD40L and OX40L and coated with NY-ESO-1 and MAGE-A3 epitopes, which potentially inhibits tumor growth (PMID: 33718594). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| PeptiCRAd-1 | PeptiCRAd1|PeptiCRAd 1 | PeptiCRAd-1 is an oncolytic adenovirus encoding CD40L and OX40L and coated with NY-ESO-1 and MAGE-A3 epitopes, which potentially inhibits tumor growth (PMID: 33718594). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|